Morbidity as a Predictor for Participation in the Danish National Mammography Screening Program: A Cross-Sectional Study

References

• Engholm G, Ferlay J, Christensen N, et al. NORDCAN–a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725–736. doi:10.3109/0284186100378201720491528
   PubMed Web of Science ®Google Scholar
• Langagergaard V, Garne JP, Vejborg I, et al. Existing data sources for clinical epidemiology: the Danish quality database of mammography screening. Clin Epidemiol. 2013;5:81–88. doi:10.2147/CLEP.S4048423526262
   PubMedGoogle Scholar
• Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition–summary document. Ann Oncol. 2008;19(4):614–622. doi:10.1093/annonc/mdm48118024988
   PubMed Web of Science ®Google Scholar
• Mikkelsen EM, Njor SH, Vejborg I. Danish quality database for mammography screening. Clin Epidemiol. 2016;8:661–666. doi:10.2147/CLEP.S9946727822113
   PubMed Web of Science ®Google Scholar
• Lynge E, Bak M, von Euler-chelpin M, et al. Outcome of breast cancer screening in Denmark. BMC Cancer. 2017;17(1):897–899. doi:10.1186/s12885-017-3929-629282034
   PubMed Web of Science ®Google Scholar
• Khaliq W, Aamar A, Wright SM. Predictors of non-adherence to breast cancer screening among hospitalized women. PLoS One. 2015;10(12):e0145492. doi:10.1371/journal.pone.014549226709510
   PubMed Web of Science ®Google Scholar
• Martinez-Huedo MA, Lopez de Andres A, Hernandez-Barrera V, Carrasco-Garrido P, Martinez HD, Jimenez-Garcia R. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010. Diabetes Metab. 2012;38(2):142–148. doi:10.1016/j.diabet.2011.09.00722078638
   PubMed Web of Science ®Google Scholar
• Martin-Lopez R, Jimenez-Garcia R, Lopez-de-Andres A, et al. Inequalities in uptake of breast cancer screening in Spain: analysis of a cross-sectional national survey. Public Health. 2013;127(9):822–827. doi:10.1016/j.puhe.2013.03.00623773337
   PubMed Web of Science ®Google Scholar
• von Euler-chelpin M, Olsen AH, Njor S, et al. Does educational level determine screening participation? Eur J Cancer Prev. 2008;17(3):273–278. doi:10.1097/CEJ.0b013e3282f0c01718414200
   PubMed Web of Science ®Google Scholar
• Tugwell P, Knottnerus JA. Multimorbidity and Comorbidity are now separate MESH headings. J Clin Epidemiol. 2019;105:vi–viii. doi:10.1016/j.jclinepi.2018.11.01930522770
   PubMed Web of Science ®Google Scholar
• Sørensen HT. Multimorbidity and cancer outcomes: a for more research. Clin Epidemiol. 2013;5(Suppl 1):1–2. doi:10.2147/CLEP.S47149
   Google Scholar
• Diaz A, Kang J, Moore SP, et al. Association between comorbidity and participation in breast and cervical cancer screening: a systematic review and meta-analysis. Cancer Epidemiol. 2017;47:7–19. doi:10.1016/j.canep.2016.12.01028086199
   PubMed Web of Science ®Google Scholar
• Deshpande AD, McQueen A, Coups EJ. Different effects of multiple health status indicators on breast and colorectal cancer screening in a nationally representative US sample. Cancer Epidemiol. 2012;36(3):270–275. doi:10.1016/j.canep.2011.10.00122079763
   PubMed Web of Science ®Google Scholar
• Kiefe CI, Funkhouser E, Fouad MN, May DS. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med. 1998;13(6):357–365. doi:10.1046/j.1525-1497.1998.00115.x9669564
   PubMed Web of Science ®Google Scholar
• Jensen LF, Pedersen AF, Andersen B, Vestergaard M, Vedsted P. Non-participation in breast cancer screening for women with chronic diseases and multimorbidity: a population-based cohort study. BMC Cancer. 2015;15:. doi:10.1186/s12885-015-1829-1
   Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449. doi:10.2147/CLEP.S9112526604824
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21. doi:10.1186/1471-2288-3-2114567763
   PubMedGoogle Scholar
• Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer. 2004;101(5 Suppl):1201–1213. doi:10.1002/cncr.2050515316915
   PubMed Web of Science ®Google Scholar
• Jensen A, Olsen AH, von Euler-chelpin M, Njor SH, Vejborg I, Lynge E. Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer. 2005;113(3):464–470. doi:10.1002/ijc.2060415455383
   PubMed Web of Science ®Google Scholar
• Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83. doi:10.1186/1471-2288-11-8321619668
   PubMed Web of Science ®Google Scholar
• Corser W, Sikorskii A, Olomu A, Stommel M, Proden C, Holmes-Rovner M. Concordance between comorbidity data from patient self-report interviews and medical record documentation. BMC Health Serv Res. 2008;8:85. doi:10.1186/1472-6963-8-8518416841
   PubMed Web of Science ®Google Scholar
• Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43. doi:10.1016/S0140-6736(12)60240-222579043
   PubMed Web of Science ®Google Scholar
• Jensen LF, Pedersen AF, Bech BH, Andersen B, Vedsted P. Psychiatric morbidity and non-participation in breast cancer screening. Breast (Edinburgh, Scotland). 2016;25:38–44. doi:10.1016/j.breast.2015.10.002
   PubMed Web of Science ®Google Scholar
• De Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77.21379357
   PubMed Web of Science ®Google Scholar
• Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120(2):104–110. doi:10.7326/0003-4819-120-2-199401150-000028256968
   PubMed Web of Science ®Google Scholar
• Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed). 1981;282(6279):1847–1851. doi:10.1136/bmj.282.6279.1847
   PubMed Web of Science ®Google Scholar